VEGFA and pachyonychia congenita: The vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF), together with their receptors, are highly expressed in PC; however, single-target anti-angiogenic agents have been studied for combined therapy in PC with limited success [75].